We have a receivables of Rs. 632 crores. That is more than our PAT and way more than our inventory, I guess. Do you see or expect any kind of significant credit loss on that?
I have just one question . Just another question, another one. There are threats to put a tariff on pharmaceuticals whose APIs are imported from China, from U.S. What kind of expected effect on CSL?